A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd, in Beijing, capital of China, March 16, 2020. (PHOTO / XINHUA)

BEIJING - China plans to support international cooperation research projects on drugs, vaccines, test kits, and traditional Chinese medicine to fight COVID-19.

A total of 100 million yuan (about US$14.26 million) from state coffers will be offered to qualified candidate projects, with the proposed project implementation period not exceeding two years

The Ministry of Science and Technology released an application guide on Monday to solicit up to 37 international anti-COVID-19 cooperation projects focusing on the four orientations. 

ALSO READ: WHO: Almost a third of COVID-19 samples show mutation

The aim is to strengthen research cooperation with virus-ravaged countries and related international organizations via innovative cooperation in international science and technology, and to share research data and experience in combating the pandemic.

Solicited projects include global multi-center clinical trials of drugs and vaccines, cooperative development of new testing technologies, and on-site quick testing equipment, as well as international research on the mechanisms of TCM in the COVID-19 treatment.

ALSO READ: Vaccine development center in Wuhan completed

Vaccine candidates that have completed Phase 1 and Phase 2 clinical trials will get priority support, according to the guide.

Each project should have at least one foreign research institute or enterprise involved. Foreign scientists employed in Chinese mainland institutes, and scientists from Hong Kong, Macao, and Taiwan can also serve as project leaders.

READ MORE: How a Chinese firm jumped to the front of the virus vaccine race

A total of 100 million yuan (about US$14.26 million) from state coffers will be offered to qualified candidate projects, with the proposed project implementation period not exceeding two years, said the ministry.

 Interested institutions can submit online applications to the ministry from July 8 to August 31.

READ MORE: Antibody diagnosis added to coronavirus treatment plan